Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Avoid common budget mistakes by knowing what not to include in a budget. This quick intro highlights pitfalls and simple tweaks to improve your spending plan.
26,809 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Want a simple way to ride the AI wave? This article explains a popular AI ETF, why it tilts toward Nvidia, Alphabet, ...
When a quarterly earnings call drops, investors seek signals that move prices. This practical guide uses the caap 202...
A strong first quarter and solid cash generation helped CVS Health's shares spark on Wednesday. This guide breaks dow...
DoorDash has become a key player in the on-demand economy. This guide breaks down what to look for, how to evaluate g...
Triata Capital's sizable stake reduction in GDS Holdings has traders and investors buzzing about AI data-center expos...
Retirees face a tricky balance: grow their nest egg while ensuring steady withdrawals. A smarter rebalance retirement...
When Netflix reportedly missed out on Roku, investors asked: what does this mean for the company’s future profits and...
Two AI-era stock stories headline this guide: Palantir as an undervalued growth play and Sandisk as a growth leader w...
As AI stocks wobble after a rapid run, investors search for steadier footing. Here's this unstoppable vanguard could ...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
A sizable stake in Pampa Energia signals renewed interest in Argentina's energy complex. This article breaks down wha...